Shares of Incyte Corp. INCY, -1.57% shed 1.57% to $69.11 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX, -0.41% falling 0.41% to 3,908.19 and Dow Jones Industrial Average DJIA, -0.55% falling 0.55% to 31,145.30. This was the stock’s second consecutive day of losses. Incyte Corp. closed $15.75 short of its 52-week high ($84.86), which the company reached on April 8th.
The stock underperformed when compared to some of its competitors Tuesday, as Pfizer Inc. PFE, +0.13% rose 0.13% to $45.76, Novartis AG ADR NVS, +0.09% rose 0.09% to $79.77, and Eli Lilly & Co. LLY, +1.82% rose 1.82% to $306.82. Trading volume (1.0 M) remained 363,086 below its 50-day average volume of 1.4 M.